<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab3">
 <label>Table 3</label>
 <caption>
  <p>Antiviral activity of hits against SARS-CoV-2 and the comparison with recently reported M
   <sup>pro</sup> inhibitors.
  </p>
 </caption>
 <table frame="hsides" rules="groups">
  <tbody>
   <tr>
    <td colspan="2">
     <inline-graphic xlink:href="41422_2020_356_Tab5_HTML.gif" id="d30e1639" xmlns:xlink="http://www.w3.org/1999/xlink"/>
    </td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <p>
   <italic>N.A.</italic> not available.
  </p>
  <p>
   <sup>a</sup>CPE EC
   <sub>50</sub>, VYR EC
   <sub>90</sub>, and cytotoxicity CC
   <sub>50</sub> values are means ± SD of 3 independent experiments.
  </p>
  <p>
   <sup>b</sup>Results were retrieved from recent publications.
   <sup>
    <xref ref-type="bibr" rid="CR8">8</xref>,
    <xref ref-type="bibr" rid="CR10">10</xref>,
    <xref ref-type="bibr" rid="CR11">11</xref>
   </sup>
  </p>
  <p>
   <sup>c</sup>The antiviral activity of ebselen was determined in plaque assay.
  </p>
 </table-wrap-foot>
</table-wrap>
